Diseases of the Cardiovascular System

Mechanisms Underlying Hypotensive Response to ARB/NEP Inhibition - Aim 3

Volunteers
Health Professionals

What is the purpose of this trial?

This is a double-blind, randomized, two x two crossover (aprepitant vs placebo) during both initiation of Entresto, LCZ696, (50 mg dose) and at steady-state of Entresto (200 mg bid dose or the highest tolerated dose).

Find out more about who can participate in this trial

Contact Information

For more information about this study, including how to volunteer, contact Christopher Maulion, MD

Help Us Discover!

You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call 877.978.8343 for more information.

Create a volunteer profile

Principal Investigator

Nancy J. Brown, MD
Jean and David W. Wallace Dean of the Yale School of Medicine and C.N.H. Long Professor of Internal Medicine

Sub-Investigators

Last Updated
10/01/2024
Study HIC
#2000028712